Ipamorelin: Clean Pulsatile GH Release
Ipamorelin is a pentapeptide that acts through the ghrelin receptor pathway:
GHSR Activation: Ipamorelin binds to growth hormone secretagogue receptors on pituitary somatotroph cells, triggering a pulse of GH release. This pulse mimics the body's natural GH secretion pattern.
Exceptional Selectivity: This is Ipamorelin's defining characteristic. Unlike GHRP-6 or GHRP-2, which also stimulate appetite (ghrelin effect), cortisol, and prolactin, Ipamorelin produces a clean GH signal with minimal hormonal side effects.
Pulsatile Release: The GH pulses triggered by Ipamorelin are physiological in nature — they rise, peak, and return to baseline. This pulsatile pattern is important because GH receptors respond better to pulses than to constant elevation.
Receptor Sensitivity: Ipamorelin's pulsatile action is less likely to cause receptor desensitisation compared to compounds that produce sustained GH elevation, potentially allowing longer research protocols.
ORYN Format: €109 for 6mg in a 30-day pen — identical pricing to CJC-1295, making the combination stack straightforward to budget.
CJC-1295: Sustained GH Amplification
CJC-1295 works through the complementary GHRH pathway:
GHRH Analogue: CJC-1295 mimics Growth Hormone Releasing Hormone, binding to GHRH receptors on the same pituitary cells that Ipamorelin targets — but through a completely different receptor.
Extended Half-Life: CJC-1295's modified structure gives it a much longer half-life than natural GHRH. This means sustained GH release rather than a brief signal — amplifying total GH output over hours rather than minutes.
Elevated Baseline: Rather than triggering individual pulses, CJC-1295 raises the baseline level of GH. This creates a persistent pro-anabolic, pro-recovery environment.
IGF-1 Amplification: The sustained GH release produces a corresponding increase in hepatic IGF-1 production, which mediates many of GH's tissue-level effects.
ORYN Format: €109 for 5mg in a 30-day pen — matching Ipamorelin's pricing for convenient stacking.
The CJC-1295 + Ipamorelin Stack: Why It Works
The combination of CJC-1295 and Ipamorelin is the most widely studied GH peptide stack, and the science behind the synergy is clear:
Dual Pathway Activation: CJC-1295 activates GHRH receptors. Ipamorelin activates GHSR receptors. These are two independent receptor systems on the same pituitary cells. Activating both simultaneously produces greater GH output than either pathway alone.
Amplified + Pulsed: CJC-1295 raises the baseline GH level. Ipamorelin triggers additional pulses on top of that elevated baseline. The result is both higher peak GH levels and greater total GH exposure.
Clean Signal: Ipamorelin's selectivity ensures the combined stack produces a clean GH response — without the cortisol, prolactin, or appetite side effects that plague less selective GH peptide combinations.
Research Protocol: Both are typically administered simultaneously, once daily, ideally before bed to align with natural GH secretion patterns. Common protocols run 8-12 weeks.
ORYN Stack Cost: €109 + €109 = €218 for two 30-day pens — one of the most affordable and evidence-backed GH research stacks available. Both pens use the same pen system for convenient dual administration.
